Filter
59
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
58
Guidelines
1
Countries / Regions
Africa
4
India
3
Latin America and the Carribbean
2
Ukraine
1
China
1
Chile
1
Nigeria
1
South–East Asia Region
1
Eastern Europe
1
Brazil
1
Russia
1
Authors & Publishers
Publication Years
Category
Guidelines
2
Disabilities
1
Neonatal Care
1
Toolboxes
Epilepsy
59
Neurological Disorders
34
Epilepsy
19
Children/Adolescents Mental Disorders
12
Training Supporting Material mhGAP
8
others
4
Africa
3
Asia
3
Latin America
2
Africa
2
Latin America
2
Asia
2
IEC Material Neurological Disorders
2
General Studies & Reports
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Studies & Reports
1
Modules
1
IEC Materials Children
1
Mental Health GAP Action Programme
1
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r...
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Bulletin de l'Organisation mondiale de la Santé 2012;90:871-871A. doi: 10.2471/BLT.12.113183
Bulletin de l'Organisation mondiale de la Santé Numéros précédents Volume 90: 2012 Volume 90, Numéro 12, décembre 2012, 869-944
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Paediatrics
Chapter I.2
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Received: 16/11/2013 - Accepted: 23/03/2014 - Published: 27/07/2014
Lancet 2012; 380: 1193–1201
Series: Epilepsy 2
